Health Canada has proposed amendments to the Medical Devices Regulations (Regulations) that would expand the regulatory framework for COVID-19 medical devices to apply to future public health emergencies (see Proposed changes to the Medical Devices Regulations to address future public health emergencies: Notice).
Under the proposed amendments, Part 1.1 of the Regulations would no longer be specific to COVID-19 medical devices. Instead, Part 1.1 would apply to medical devices that have an urgent public health need (UPHN) in relation to a medical condition for which there is a public health emergency. The proposed amendments would also:
- allow the Minister of Health (Minister) to add a medical condition to the List of Medical Devices for an Urgent Public Health Need in Relation to COVID-19 where specific criteria are met;
- allow for the inclusion of additional medical conditions on the List of Medical Devices for Expanded Use in Relation to COVID-19 (and any other relevant provisions) when necessary; and
- allow the Minister to issue an authorization even if the UPHN status of a device changes after a manufacturer submits an application for authorization in respect of that device.
The proposed amendments also address amendments to authorizations, requirements to inform the Minister of foreign authorization/licence revocation or suspension, and fee requirements and exemptions. Health Canada’s consultation on the proposed amendments closed on April 13, 2023.
Should you have any questions, please do not hesitate to contact a member of the Life Sciences Regulatory & Compliance Group.
The preceding is intended as a timely update on Canadian intellectual property and technology law. The content is informational only and does not constitute legal or professional advice. To obtain such advice, please communicate with our offices directly.
Related Publications & Articles
-
Health Canada proposes amendments to the Food and Drug Regulations and Medical Devices Regulations to modernize framework for therapeutic product recalls
On April 15, 2023, Health Canada proposed amendments to the Food and Drug Regulations and the Medical Devices Regulations (together, the “Proposed Amendments”).Read More -
Proposed legislation for patent term adjustment, and the interplay with CSPs
Bill C-47 is an omnibus bill that includes proposed amendments to the Patent Act to introduce patent term adjustment to compensate the patentee for Patent Office delays in granting a patent.Read More -
Health Canada publishes revised Guidance Document: Certificates of Supplementary Protection (CSP)
On May 12, 2023, Health Canada announced the fifth version of the Guidance Document: Certificates of Supplementary Protection. The changes are desRead More